Juan M. Hincapie-Castillo/LinkedIn
Feb 28, 2026, 03:58
Juan M. Hincapie-Castillo: FDA Releases Draft 2026 Guidance Plans Including Endometriosis-Associated Pain
Juan M. Hincapie-Castillo, Associate Professor at University of Pittsburgh, shared a post on LinkedIn:
“The FDA Center for Drug Evaluation and Research released its New and Revised Draft Guidances Planned for Publication in CY 2026.
A few that stand out to me working in RWE, drug safety, and pain:
- Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products
- Considerations for the Inclusion of Older Adults in Clinical Trials
- Endometriosis-Associated Pain: Establishing Effectiveness and Safety of Drugs for Management
- Sickle Cell Disease: Endpoints for the Development of Products for Prevention and Treatment of SCD Complications
- Development of a Shared System or Separate REMS.”
Proceed to the pages attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 29, 2026, 01:03Seeking a Second Opinion Is Not Being Difficult, It Is a Valid Part of Informed Care – PCOS Awareness Association
-
Jul 29, 2026, 00:57Szabo Gabor: IOTA Day 2026 Advancing Ultrasound in Gynaecological Oncology
-
Jul 29, 2026, 00:55Islam Badr: A Simple Approach to Fetal Heart Screening
-
Jul 29, 2026, 00:50Hardeep Singh: Understanding the Global IVF Travel Landscape
-
Jul 29, 2026, 00:48Asma Khatun: Shaping the Future of Women’s Healthcare at GFWH 2026
-
Jul 29, 2026, 00:43Shaping the Future of Reproductive Medicine at ASRM Innovate – ASRM
-
Jul 29, 2026, 00:37George Condous: Gratitude Makes Every Achievement Greater!
-
Jul 29, 2026, 00:35As AMH Falls, Progesterone May Rise Earlier in Ovarian Stimulation! – Fertility Plus
-
Jul 29, 2026, 00:33An Easy Method for Systematic Fetal Cardiac Screening – ISUOG
